GlassScriptPhysician profile
Rajendra H Solanki
NPI 1356331714
$24,454.10
in general payments reported to CMS, 2019-2025
39 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $6,047 · 2021: $708 · 2022: $925 · 2023: $1,006 · 2024: $1,084 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,298.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17,792.62 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,268.31 | 2019-2025 | |
| Amgen INC. | $1,178.25 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $702.04 | 2021-2025 | Symplicity G3, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $397.51 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.19 | 2019-2025 | Jardiance |
| Pfizer INC. | $312.00 | 2019-2025 | |
| Shockwave Medical, INC | $228.71 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $225.99 | 2020-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $213.24 | 2019-2025 | Jot Dx, Confirm Rx, Aveir |
| Merck Sharp & Dohme LLC | $201.52 | 2022-2025 | Verquvo, Capvaxive |
| Medtronic Vascular, INC. | $193.18 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $192.88 | 2019-2024 | Farxiga |
| Angiodynamics, INC. | $127.81 | 2022 | |
| Sanofi-Aventis U.S. LLC | $102.42 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $93.59 | 2022-2025 | |
| Irhythm Technologies, INC. | $84.04 | 2019-2023 | Zio Xt Patch |
| Scpharmaceuticals INC. | $82.28 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $80.21 | 2024 | Arcalyst |
| Novo Nordisk INC | $76.27 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Astellas Pharma US INC | $68.18 | 2019-2021 | |
| Abiomed | $56.41 | 2023-2025 | Impella |
| Janssen Pharmaceuticals, INC | $56.06 | 2019 | |
| Kestra Medical Technology Services, INC. | $41.88 | 2025 | Assure Wcd |
| Atricure, INC. | $33.61 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Lexicon Pharmaceuticals, INC. | $32.27 | 2024 | |
| United Therapeutics Corporation | $30.87 | 2019 | |
| Gilead Sciences, INC. | $24.03 | 2019 | |
| Esperion Therapeutics, INC. | $21.28 | 2024 | Nexletol |
| Penumbra, INC. | $20.67 | 2025 | Indigo System |
| Philips North America LLC | $18.84 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Teleflex LLC | $18.36 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.69 | 2022 | |
| Vital Connect, INC | $17.64 | 2025 | Vitalpatch Rtm |
| Baxter Healthcare | $15.03 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Cardiovascular Systems INC. | $13.82 | 2020 | |
| Boston Scientific Corporation | $13.23 | 2024 | |
| Alnylam Pharmaceuticals INC. | $13.18 | 2021 | |
| Medicomp INC | $12.99 | 2023 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajendra Solanki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.